Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download
07 Oct 2021 Liquidity and counterparty agreements Download
04 Oct 2021 Liquidity and counterparty agreements Download
01 Sep 2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine Download

Pages

Date Title Description PDF
27 Apr 2016 Información sobre resultados (2) The Company releases the press release related to the 2016 first quarter results Download
27 Apr 2016 Información sobre resultados The Company releases the press release related to the 2016 first quarter results Download
27 Apr 2016 Convocatorias y Acuerdos de Juntas y Asambleas Generales ROVI informs about the call for the General Shareholders Meeting Download
04 Apr 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2016 - correction Download
01 Apr 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2016 Download

Pages